- Nachrichtendetail
-
02.02.2024 12:22:52 - dpa-AFX: *REGENERON PHARMA: EMA ACCEPTS FOR REVIEW MAA FOR LINVOSELTAMAB TO TREAT R/R MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 909,200 | 03.06.24 14:09:52 | +10,800 | +1,20% | 899,200 | 909,400 | 900,200 | 898,400 |
